These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23087911)

  • 1. Growth conditions and environmental factors impact aerosolization but not virulence of Francisella tularensis infection in mice.
    Faith SA; Smith LP; Swatland AS; Reed DS
    Front Cell Infect Microbiol; 2012; 2():126. PubMed ID: 23087911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro.
    Hazlett KR; Caldon SD; McArthur DG; Cirillo KA; Kirimanjeswara GS; Magguilli ML; Malik M; Shah A; Broderick S; Golovliov I; Metzger DW; Rajan K; Sellati TJ; Loegering DJ
    Infect Immun; 2008 Oct; 76(10):4479-88. PubMed ID: 18644878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, Characterization, and Standardization of a Nose-Only Inhalation Exposure System for Exposure of Rabbits to Small-Particle Aerosols Containing Francisella tularensis.
    O'Malley KJ; Bowling JD; Barry EM; Hazlett KRO; Reed DS
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31085702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Growth of
    Holland KM; Rosa SJ; Kristjansdottir K; Wolfgeher D; Franz BJ; Zarrella TM; Kumar S; Sunagar R; Singh A; Bakshi CS; Namjoshi P; Barry EM; Sellati TJ; Kron SJ; Gosselin EJ; Reed DS; Hazlett KRO
    Front Microbiol; 2017; 8():1158. PubMed ID: 28690600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
    Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
    mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
    Ark NM; Mann BJ
    Microb Pathog; 2011 Sep; 51(3):110-20. PubMed ID: 21605655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased encapsulation and virulence of Francisella tularensis live vaccine strain (LVS) by subculturing on synthetic medium.
    Cherwonogrodzky JW; Knodel MH; Spence MR
    Vaccine; 1994 Jul; 12(9):773-5. PubMed ID: 7975855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen.
    Shen H; Chen W; Conlan JW
    Vaccine; 2004 Jun; 22(17-18):2116-21. PubMed ID: 15149767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation and mutagenesis of a capsule-like complex (CLC) from Francisella tularensis, and contribution of the CLC to F. tularensis virulence in mice.
    Bandara AB; Champion AE; Wang X; Berg G; Apicella MA; McLendon M; Azadi P; Snyder DS; Inzana TJ
    PLoS One; 2011 Apr; 6(4):e19003. PubMed ID: 21544194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
    Kieffer TL; Cowley S; Nano FE; Elkins KL
    Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
    Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
    Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.
    Li J; Ryder C; Mandal M; Ahmed F; Azadi P; Snyder DS; Pechous RD; Zahrt T; Inzana TJ
    Microbiology (Reading); 2007 Sep; 153(Pt 9):3141-3153. PubMed ID: 17768257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular immune responses to aerosol challenge with Francisella tularensis in mice inoculated with live vaccine candidates of varying efficacy.
    Shen H; Harris G; Chen W; Sjostedt A; Ryden P; Conlan W
    PLoS One; 2010 Oct; 5(10):e13349. PubMed ID: 20967278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis.
    Chen W; KuoLee R; Shen H; Conlan JW
    Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.